4-phenylpyridine has been researched along with selegiline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, KS; Huang, CC; Su, MT; Tsai, JJ | 1 |
| Hsu, KS; Huang, CC; Tsai, JJ | 1 |
2 other study(ies) available for 4-phenylpyridine and selegiline
| Article | Year |
|---|---|
L-deprenyl (selegiline) decreases excitatory synaptic transmission in the rat hippocampus via a dopaminergic mechanism.
Topics: Animals; Anticonvulsants; Dopamine; Dose-Response Relationship, Drug; Glutamine; Hippocampus; In Vitro Techniques; Male; Monoamine Oxidase Inhibitors; N-Methylaspartate; Pargyline; Picrotoxin; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Selegiline; Synaptic Transmission | 1996 |
L-deprenyl (selegiline) limits the repetitive firing of action potentials in rat hippocampal CA1 neurons via a dopaminergic mechanism.
Topics: Action Potentials; Analysis of Variance; Animals; Antiparkinson Agents; Dopamine; In Vitro Techniques; Male; Membrane Potentials; Monoamine Oxidase Inhibitors; Pargyline; Pyramidal Cells; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Selegiline | 1997 |